$38.48 0.16 (0.42%)
16:36 EST PFE Stock Quote Delayed 15 Minutes
Previous Close $38.32
Market Cap 225.09B
PE Ratio 10.69
Volume (Avg. Vol.) 18.18M
Day's Range 38.19 - 38.58
52-Week Range 33.97 - 44.90
Dividend & Yield 1.36 (3.53%)
PFE Stock Predictions, Articles, and Pfizer News
- From InvestorPlace
- From the Web
The lagging healthcare sector has been building momentum and that boosted the Dow Jones Industrial Average today.
Friday's 3 big stock charts highlight 3 names looking for help from a market at all-time highs.
There's a strong case for investing in Pfizer stock. With a great deal of uncertainty in the near-term, however, some patience with PFE stock may be required.
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
The S&P 500 hit another new all-time high on Tuesday. Here's what happened in the stock market today to get it there.
GrubHub, Shopify, Apple, Pfizer and General Motors were our top stock trades from Tuesday. Here's a look at the charts.
Options trading was hot in Fitbit, Pfizer, and Twitter on Monday. Here’s what the data suggests moving forward.
Akcea Therapeutics (AKCA) stock is flying high on Monday following news of a $250 million deal with Pfizer (NYSE:PFE) for licensing rights.
Seagate, AT&T and Citigroup are just three of the blue-chip dividend stocks that have become cheap stocks to buy recently.
Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.
PFE stock recently dropped 20% following the company's latest earnings report. As a result, Pfizer has reached extreme oversold readings that could lead to a pop in the stock.
Even though they are prone to headlines during elections, here are 3 healthcare stocks to buy: PFE, UNH and JNJ.
The stock charts of Pfizer, AES and Centurylink have emerged as enticing prospects within a sea of volatility.
Q2 earnings season rolls on and Wall Street tries to not act disappointed by the early end to the latest round of U.S.-China trade talks. Thus, individual stock price action is uneven with all the focus going to a handful of names posting solid results.
Options trading was buzzing in Pfizer, Advanced Micro Devices and Apple on Tuesday. Here are the metrics that matter moving forward.
The stock charts of Southern Co, CF Industries Holdings and National-Oilwell Varco are at inflection points at the midpoint of the week.
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader